PolyCore Therapeutics has secured a seed investment to advance its lead compound PCT-3012, designed to treat motor symptoms in…
Articles by Patricia Inácio, PhD
Neuropore Therapies has received a $4.8 million grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to develop…
Lucy Therapeutics (LucyTx) has received a $4.9 million, two-year grant from the Michael J. Fox Foundation…
The Michael J. Fox Foundation (MJFF) has named Brit Mollenhauer, MD, a foundation scientific advisor, as the winner…
Practicing tai chi for a year improved gait and balance in early-stage Parkinson’s disease patients, improving both inflammation and…
Scientists have created a set of sensors that can help measure muscle strain and bulging while integrated in a wearable device,…
Using Cerevance’s oral CVN424 as an add-on therapy for Parkinson’s motor symptoms led to a significant and meaningful…
Vyant Bio and OrganoTherapeutics are teaming up to speed the discovery of new candidates for treating Parkinson’s…
The first patient has been dosed in a Phase 3 trial testing GE Healthcare’s new dopamine transporter…
IMAC Holdings has started dosing the third and final group of participants in a Phase 1 clinical trial assessing…